Soluble CD40 Ligand in Morbidly Obese Patients

JAMA Surgery - United States
doi 10.1001/jamasurgery.2013.419
Full Text
Abstract

Available in full text

Categories
Surgery
Date
Authors
Publisher

American Medical Association (AMA)

Related search

Soluble CD40 Ligand in Dementia

Drugs of the Future
Pharmacology
2009English

Soluble CD40 Ligand in Acute Coronary Syndromes

ACC Current Journal Review
2003English

Recombinant Soluble Trimeric CD40 Ligand Is Biologically Active

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1995English

PEG Tube Placement in Morbidly Obese Patients

Endoscopy
Gastroenterology
2012English

Airway Tube Exchanger Techniques in Morbidly Obese Patients

Anesthesiology Research and Practice
Critical CareAnesthesiologyPain MedicineIntensive Care Medicine
2012English

Macaque Multimeric Soluble CD40 Ligand and GITR Ligand Constructs Are Immunostimulatory Molecules in Vitro

Clinical and Vaccine Immunology
MedicineImmunologyAllergyClinical BiochemistryMicrobiology
2006English

Post Dural Puncture Headache in Morbidly Obese Patients

Canadian Journal of Anaesthesia
MedicineAnesthesiologyPain Medicine
2006English

Rheological Red Blood Cell Properties in Morbidly Obese and Super Obese Patients

Clinical Hemorheology and Microcirculation
PhysiologyCardiovascular MedicineHematologyCardiology
2014English

Propofol Induction: Normalizing the Dose in Morbidly Obese Patients

Canadian Journal of Anaesthesia
MedicineAnesthesiologyPain Medicine
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy